NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said after the close of the market on Tuesday that revenues in the second quarter were down 2 percent year over year, as the firm missed analysts' estimate on the top line.

For the three months ended June 30, the Hercules, Calif.-based company recorded revenues of $510.4 million, down from $521.7 million and below the consensus Wall Street estimate of $524.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.